BPC 157: The Real Reason Why It's Not FDA Approved Stracuzzi Wellness BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with Big news in the peptide world. , The FDA has scheduled a formal hearing in July to review 7 peptides including BPC 157 and TB 500 for legal compounding. , This isnt approval. But its BPC 157 and ipamorelin under FDA scrutiny Alex Keoskey posted on the topic LinkedIn BPC 157 and Healing Peptides: Hype or Hope? A Doctor's Comprehensive Perspective MSK Doctor Zaid Matti